These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2252150)

  • 21. [Cervical cancer screening for high risk women: is it possible? Results of a cervical cancer screening program in three suburban districts of Lyon].
    Mignotte H; Perol D; Fontanière B; Nachury LP; Blanc-Jouvand A; Fouillat V; Chauvin F; Lasset C
    Bull Cancer; 1999 Jun; 86(6):573-9. PubMed ID: 10417430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Screening for malignant gynecologic tumors].
    Ebeling K
    Z Arztl Fortbild (Jena); 1993 Sep; 87(9):715-9. PubMed ID: 8237067
    [No Abstract]   [Full Text] [Related]  

  • 23. [The role of the cytological screening, HPV-test and the colposcopy for early detection of the precancerous lesions of the uterine cervix].
    Ivanov S
    Akush Ginekol (Sofiia); 2007; 46(9):45-9. PubMed ID: 18646309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathways to diagnosis of cervical cancer: screening history, delay in follow up, and smear reading.
    Priest P; Sadler L; Peters J; Crengle S; Bethwaite P; Medley G; Jackson R
    BJOG; 2007 Apr; 114(4):398-407. PubMed ID: 17166215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Role of examination offices in preventing genital cancer in women of retirement age].
    Alekhnovich MV
    Vopr Onkol; 1974; 20(9):103-6. PubMed ID: 4279497
    [No Abstract]   [Full Text] [Related]  

  • 26. Evaluation of causes of increased incidence of cervical cancer in Slovenia.
    Smrkolj S; Rakar S; Mozina A; Erzen M
    Eur J Obstet Gynecol Reprod Biol; 2004 Dec; 117(2):213-21. PubMed ID: 15541860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Consequences of incorrect interpretation of vaginal smear tests in a screening program].
    Lynge E; Arffmann E; Poll P; Andersen PK
    Ugeskr Laeger; 1994 Apr; 156(17):2594-6. PubMed ID: 8016968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Correlation between oncologically suspicious cytologic smears and colposcopic images of the uterine cervix and results of histopathologic examination taken from material provided by the Gynecology Department of the Pruszkow Municipal Hospital from 1995 to 1997].
    Czekanowski R; Pietrzak M; Kukulski P
    Przegl Lek; 1999; 56(1):48-50. PubMed ID: 10375926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Analysis of the intralaboratory diagnostic variability in the Imola cervical screening program].
    Fabbris E; Bucchi L; Folicaldi S; Amadori A; Ghidoni D; Medri M; Bondi A
    Pathologica; 1998 Apr; 90(2):127-32. PubMed ID: 9619055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening and early diagnosis of gynecologic cancers.
    Warner EA; Parsons AK
    Med Clin North Am; 1996 Jan; 80(1):45-61. PubMed ID: 8569300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Performance of a semiautomated Papanicolaou smear screening system: results of a population-based study conducted in Guanacaste, Costa Rica.
    Sherman ME; Schiffman M; Herrero R; Kelly D; Bratti C; Mango LJ; Alfaro M; Hutchinson ML; Mena F; Hildesheim A; Morales J; Greenberg MD; Balmaceda I; Lorincz AT
    Cancer; 1998 Oct; 84(5):273-80. PubMed ID: 9801201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Statistical results of preventive cancer care in women].
    Soost HJ
    Fortschr Med; 1974 Mar; 92(9):360-2. PubMed ID: 4819504
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
    Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
    BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effectiveness of use of cytological method of examination in mass preventive screening of the female population of the Republic].
    Zaĭsanova TK; Akbasheva MI
    Zdravookhr Kirg; 1975; (4):6-9. PubMed ID: 1932
    [No Abstract]   [Full Text] [Related]  

  • 35. [The role of Papanicolaou test in gynecologic practice].
    Grio R; Piacentino R; Ferrara L; Condello V; Fuda G; Caccuri D; Giobbe C; Marchino GL
    Minerva Ginecol; 1991 Sep; 43(9):393-4. PubMed ID: 1945026
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Field test and experimental use of CYBEST model 2 for practical gynecologic mass screening.
    Tanaka N; Ikeda H; Ueno T; Mukawa A; Kamitsuma K
    Anal Quant Cytol; 1979; 1(2):122-6. PubMed ID: 543573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening for gynecologic cancer.
    Campion MJ; Reid R
    Obstet Gynecol Clin North Am; 1990 Dec; 17(4):695-727. PubMed ID: 2092238
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening for gynecologic cancer.
    Zanotti KM; Kennedy AW
    Med Clin North Am; 1999 Nov; 83(6):1467-87. PubMed ID: 10584603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cytological mass screening, its current status and future prospects].
    Döbrössy L; Bodó M; Sugár J
    Orv Hetil; 1977 Sep; 118(36):2131-4. PubMed ID: 917504
    [No Abstract]   [Full Text] [Related]  

  • 40. [Prophylactic gynecologic examinations in a stationary region].
    Flach W; Büchner C; Pressler H
    Zentralbl Gynakol; 1977; 99(7):422-8. PubMed ID: 868366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.